News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
121,142 Results
Type
Article (17214)
Company Profile (105)
Press Release (103928)
Multimedia
Podcasts (243)
Webinars (20)
Section
Business (42069)
Career Advice (849)
Deals (6463)
Drug Delivery (111)
Drug Development (15448)
Employer Resources (144)
FDA (2228)
Job Trends (3383)
News (59042)
Policy (5103)
Tag
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (527)
Academic (1)
Accelerated approval (16)
ADA (12)
Adcomms (16)
Allergies (34)
Alliances (10150)
ALS (45)
Alzheimer's disease (520)
Antibody-drug conjugate (ADC) (156)
Approvals (2032)
Artificial intelligence (309)
ASCO (78)
Autoimmune disease (95)
Automation (17)
Bankruptcy (74)
Best Places to Work (1604)
BIO (81)
Biologics (1)
BIOSECURE Act (16)
Biosimilars (70)
BioSpace Insights (232)
Biotechnology (69)
Bladder cancer (40)
Brain cancer (20)
Breast cancer (96)
Cancer (1178)
Cardiovascular disease (146)
Career advice (762)
Career pathing (41)
CAR-T (109)
CDC (31)
Celiac Disease (2)
Cell therapy (380)
Cervical cancer (4)
Clinical research (11674)
Collaboration (647)
Commercialization (4)
Company closure (7)
Compensation (179)
Complete response letters (24)
COVID-19 (1364)
CRISPR (44)
C-suite (406)
Cystic fibrosis (33)
Data (1369)
Decentralized trials (2)
Denatured (99)
Depression (47)
Dermatology (8)
Diabetes (117)
Diagnostics (1062)
Digital health (5)
Diversity (11)
Diversity, equity & inclusion (41)
Drug discovery (158)
Drug pricing (88)
Drug shortages (12)
Duchenne muscular dystrophy (82)
Earnings (11717)
Editorial (56)
Employer branding (22)
Employer resources (119)
Events (21089)
Executive appointments (326)
FDA (2736)
Friedreich's ataxia (9)
Frontotemporal dementia (9)
Funding (671)
Gene editing (105)
Generative AI (44)
Gene therapy (314)
GLP-1 (454)
Government (1151)
Grass and pollen (2)
Guidances (49)
Healthcare (2073)
Hematology (34)
HIV (12)
Huntington's disease (27)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (36)
Immunology and inflammation (144)
Immuno-oncology (43)
Indications (26)
Infectious disease (1434)
Inflammatory bowel disease (44)
Inflation Reduction Act (11)
Influenza (21)
Intellectual property (62)
Interviews (140)
IPO (2476)
IRA (27)
Job creations (1625)
Job search strategy (653)
JPM (61)
Kidney cancer (1)
Labor market (125)
Layoffs (339)
Leadership (25)
Legal (1181)
Licensing (3)
Liver cancer (25)
Longevity (15)
Lung cancer (212)
Lymphoma (78)
Machine learning (31)
Management (34)
Manufacturing (470)
Marketing (3)
MASH (55)
Medical device (963)
Medtech (1005)
Mergers & acquisitions (4243)
Metabolic disorders (458)
mRNA (177)
Multiple sclerosis (46)
NASH (8)
Neurodegenerative disease (167)
Neuropsychiatric disorders (31)
Neuroscience (917)
Neurotech (1)
NextGen: Class of 2026 (1415)
Non-profit (318)
Now hiring (82)
Obesity (260)
Opinion (204)
Ovarian cancer (33)
Pain (49)
Pancreatic cancer (47)
Parkinson's disease (85)
Partnered (28)
Patents (137)
Patient recruitment (138)
Peanut (6)
People (12938)
Pharmaceutical (14)
Pharmacy benefit managers (10)
Phase 1 (4205)
Phase 2 (5614)
Phase 3 (4051)
Pipeline (1927)
Policy (220)
Postmarket research (192)
Preclinical (1783)
Press Release (22)
Prostate cancer (37)
Psychedelics (55)
Radiopharmaceuticals (74)
Rare diseases (389)
Real estate (1561)
Recruiting (55)
Regulatory (4035)
Reports (65)
Research institute (474)
Resumes & cover letters (120)
Rett syndrome (7)
RNA editing (20)
RSV (9)
Schizophrenia (40)
Series A (164)
Series B (112)
Service/supplier (2)
Sickle cell disease (27)
Special edition (32)
Spinal muscular atrophy (23)
Sponsored (27)
Startups (1415)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (33)
The Weekly (141)
Vaccines (580)
Venture capital (113)
Weight loss (194)
Women's health (40)
Worklife (19)
Date
Today (29)
Last 7 days (139)
Last 30 days (506)
Last 365 days (6038)
2026 (3938)
2025 (5742)
2024 (7071)
2023 (7790)
2022 (10500)
2021 (10549)
2020 (8348)
2019 (5913)
2018 (4297)
2017 (5979)
2016 (6231)
2015 (6973)
2014 (5011)
2013 (3778)
2012 (4108)
2011 (4121)
2010 (3898)
Location
Africa (364)
Alabama (16)
Alaska (1)
Arizona (44)
Arkansas (2)
Asia (10263)
Australia (1323)
California (2985)
Canada (512)
China (423)
Colorado (92)
Connecticut (105)
Delaware (83)
Europe (17178)
Florida (462)
Georgia (43)
Hawaii (2)
Idaho (13)
Illinois (170)
India (28)
Indiana (48)
Iowa (6)
Japan (120)
Kansas (24)
Kentucky (5)
Louisiana (8)
Maine (2)
Maryland (300)
Massachusetts (1864)
Michigan (32)
Minnesota (93)
Mississippi (1)
Missouri (25)
Montana (4)
Nebraska (4)
Nevada (83)
New Hampshire (11)
New Jersey (579)
New Mexico (14)
New York (549)
North Carolina (435)
North Dakota (2)
Northern California (1538)
Ohio (76)
Oklahoma (11)
Oregon (7)
Pennsylvania (605)
Puerto Rico (11)
Rhode Island (5)
South America (385)
South Carolina (3)
South Dakota (1)
Southern California (1041)
Tennessee (22)
Texas (486)
United States (9010)
Utah (69)
Virginia (33)
Washington D.C. (19)
Washington State (173)
West Virginia (1)
Wisconsin (20)
121,142 Results for "abilita bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Abilita Bio Changes Name to Abilita Therapeutics and Appoints Joel Edwards as Chief Business Officer
Abilita Bio, a leader in enabling the discovery of membrane protein-targeted therapeutics, announced today the company changed its name to Abilita Therapeutics.
June 1, 2023
·
3 min read
Press Releases
BIO 2026 – Cytomos showcases groundbreaking new digital platform AuraCyt®, which enables earlier, smarter bioprocessing decisions
At this year’s annual meeting of the Bio International Convention (BIO) in San Diego, CA, TechBio company Cytomos (www.cytomos.com) is showcasing their flagship cell analytic intelligence platform AuraCyt® – together with its novel benchtop technology Celledonia® – which is set to revolutionise predictive cell analytics.
June 22, 2026
·
1 min read
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
Speaking to media on Tuesday, BIO CEO John Crowley complimented China’s rise as a biotech powerhouse but said U.S. policy needs to protect and maintain America’s lead.
June 24, 2026
·
2 min read
·
Annalee Armstrong
China
BIO outshines World Cup as biotech celebrates 50th anniversary with a ‘call to action’
At the BIO International Convention in San Diego, attendees marked the 50th anniversary of original biotech Genentech, reflecting on the immense challenges facing companies as China becomes a powerhouse innovator.
June 30, 2026
·
4 min read
·
Annalee Armstrong
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
Eli Lilly joins hands with Engage Bio, acquiring the DNA delivery platform developer in hopes of bolstering its genetic medicines portfolio.
May 20, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Bio-Techne Corrects Dividend Announcement
August 13, 2026
·
3 min read
Antibody-drug conjugate
Can ADCs be kinder and gentler? Join
BioSpace
at BIO to find out
While existing antibody-drug conjugates have been incredible advancements in cancer care, patients are ready for a better experience. At the BIO International Convention in San Diego on Thursday,
BioSpace
will lead a discussion on the next generation of ADCs.
June 23, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Spear Bio’s SPEAR UltraDetect™ BD-pTau 217 Assay Named a 2026 R&D 100 Award Winner
August 11, 2026
·
3 min read
Policy
BIO 2026: US public health as we know it is gone. Can we rebuild a better system?
Former FDA, CDC and NIH leaders convene at the BIO International Convention to discuss the dismantling of the Department of Health and Human Services under the Trump administration—and where we go from here.
June 23, 2026
·
4 min read
·
Jef Akst
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
The vibe at BIO 2026 in San Diego last week was overwhelmingly positive, with attendees observing noticeable changes at the FDA and an uptick in dealmaking and IPOs. Plus, a top medical journal this week retracted a pivotal study for Amgen’s rare disease drug Tavneos, which has been in the FDA’s crosshairs since January.
July 1, 2026
·
2 min read
·
Jef Akst
1 of 12,115
Next
